Gastro-retentive levodopa delivery form

作者: Kenneth I. Cumming , Mary L. Martin , Zebunnissa Ramtoola

DOI:

关键词:

摘要: Gastro-retentive dosage forms for prolonged delivery of levodopa and carbidopa­levodopa combinations are described. The comprise a tablet containing the active ingredient gas-generating agent sealed within an expandable, hydrophilic, water-permeable substantially gas-impermeable membrane. Upon contact with gastric fluid, membrane expands as result release gas from in tablet. expanded is retained stomach period time up to 24 hours or more during which released providing site optimum absorption upper small intestine.

参考文章(17)
Joel Sinnreich, Covered retard forms ,(1988)
Kari Vahervuo, Jarmo Lintulaakso, Marja Partanen, Matti Virkki, Marja Ritala, Mervi Niskanen, Marja Laaksonen, Sari Kallioinen, Lasse Kervinen, Pharmaceutical composition comprising entracapone, levodopa, and carbidopa ,(2002)
William John Curatolo, Jeelin Lo, Gastric retention system for controlled drug release ,(1989)
Sumio Watanabe, Yasuo Miyake, Masaki Ichikawa, Granule remaining in stomach ,(1987)
Michael Roreger, Bodo Asmussen, Karsten Cremer, Hans-Rainer Hoffmann, Karin Ludwig, Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract ,(1998)
Edith Leistner, Sabine Freitag, Margit Haase, Frank-Michael Albert, Udo Wenzel, Jürgen Metzner, Günther Weber, Frank-Ulrich Flöther, Alfred Därr, Orally administerable drugs for the treatment of central dopamine deficiency conditions ,(1992)
Crystal Pollock-Dove, Liang C. Dong, David E. Edgren, Patrick S. L. Wong, Controlled release liquid active agent formulation dosage forms ,(2001)